Treatment · Neuromodulation
Reduce the signal — not the identity.
Movement is part of facial identity. Botulinum toxin can soften selected movement-related lines by reducing targeted muscular activity — the objective is not automatically to remove all expression, but to understand which muscles are contributing to the concern and what degree of change is appropriate.
What this treats
This treatment family is considered when a movement-related line — not a static one — is the primary finding.
How the technology is chosen
Controlled change, not maximum change.
A technically successful injection is not necessarily a natural result if the face no longer moves in a way that belongs to the patient. The objective is controlled change — a face that may look more rested or balanced without the treatment itself being identifiable. How much to soften, and where, follows from which muscles are actually contributing to the concern, not a standard approach applied the same way to every patient.
Technology options
One option exists within this family. Whether it applies follows from assessment — not from this list.
- 01
Botulinum toxin
Movement is part of facial identity.
Can soften selected movement-related lines and other medically appropriate concerns depending on the selected product and jurisdiction. Treatment begins with understanding which muscles are contributing to the concern and how they interact, not with a default dose applied uniformly.
When another approach may make more sense
Not every line is a movement-related line. Static lines, volume loss, skin quality change or structural change can look similar at rest and may call for a different treatment family within this system — or a medical evaluation before any procedure.
Before your consultation
Bring the movement, not the answer.
You don't need to know which muscles are involved. That's what assessment is for.